These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3247141)

  • 1. [Vitreous fluorophotometry in diabetics using an insulin pump: absent or minimal retinopathy].
    Zaluski S; Calvet L; Selam JL; Mirouze J; Martin G
    Ophtalmologie; 1988; 2(2):101-4. PubMed ID: 3247141
    [No Abstract]   [Full Text] [Related]  

  • 2. [Surveillance using vitreo-fluoro-photometry of diabetics treated with an insulin pump, without or with minimal retinopathy. Results after 3 years].
    Bordat B; Misse P; Zaluski S; Rouault R; Mirouze J
    J Fr Ophtalmol; 1989; 12(6-7):421-5. PubMed ID: 2636237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fluorophotometry of the vitreous body in diabetics without retinopathy or with minimal retinopathy].
    Bordat B; Guirgis IR; Manderscheid JC
    J Fr Ophtalmol; 1990; 13(6-7):343-7. PubMed ID: 2290006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fluorophotometry of the vitreous body in insulin-dependent diabetes mellitus with minimal retinopathy or without it].
    Roy MS; Podgor MJ; Grunberger G; Carl J; Bungay P; Ellis D
    Ophtalmologie; 1987; 1(2):151-4. PubMed ID: 3153837
    [No Abstract]   [Full Text] [Related]  

  • 5. Vitreous fluorophotometry in juvenile diabetes.
    Kernell A; Larsson Y; Ludvigsson J; Tenland T
    Acta Endocrinol Suppl (Copenh); 1980; 238():67-74. PubMed ID: 6933816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Insulin pumps for insulin-dependent diabetics].
    Millet P; Selam JL; Boudet C
    Annee Ther Clin Ophtalmol; 1983; 34():99-109. PubMed ID: 6679709
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of vitreous fluorophotometry to distinguish between diabetics with and without observable retinopathy: effect of vitreous abnormalities on the measurement.
    Prager TC; Chu HH; Garcia CA; Anderson RE; Field JB; Orzeck EA; Comstock JP
    Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):57-65. PubMed ID: 6826315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rapid deterioration of diabetic retinopathy and treatment using an insulin pump].
    Risse JF; Boissonnot M; Marechaud R; Benois E; Sudre Y
    Bull Soc Ophtalmol Fr; 1988 May; 88(5):679-80, 681-3. PubMed ID: 3067893
    [No Abstract]   [Full Text] [Related]  

  • 9. Sequential vitreous fluorophotometry in diabetes mellitus: a five-year prospective study.
    Waltman SR
    Trans Am Ophthalmol Soc; 1984; 82():827-49. PubMed ID: 6535330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diabetic retinopathy with continuous subcutaneous insulin infusion therapy (insulin pump)].
    Bernsmeier H; Sonnenberg GE
    Fortschr Ophthalmol; 1984; 81(3):267-70. PubMed ID: 6479784
    [No Abstract]   [Full Text] [Related]  

  • 11. Vitreous fluorophotometric evaluation of diabetics.
    Bursell SE; Delori FC; Yoshida A; Parker JS; Collas GD; McMeel JW
    Invest Ophthalmol Vis Sci; 1984 Jun; 25(6):703-10. PubMed ID: 6724841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorophotometry in juvenile-onset diabetes: long-term follow-up.
    Krupin T; Waltman SR
    Jpn J Ophthalmol; 1985; 29(2):139-45. PubMed ID: 4046222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative vitreous fluorophotometry. A sensitive technique for measuring early breakdown of the blood-retinal barrier in young diabetic patients.
    Waltman SR; Oestrich C; Krupin T; Hanish S; Ratzan S; Santiago J; Kilo C
    Diabetes; 1978 Feb; 27(2):85-7. PubMed ID: 624444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy.
    Hogeboom van Buggenum IM; Polak BC; Reichert-Thoen JW; de Vries-Knoppert WA; van Hinsbergh VW; Tangelder GJ
    Diabetologia; 2002 Feb; 45(2):203-9. PubMed ID: 11935151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitreous fluorophotometry and hemoglobin AIc in non-proliferative diabetic retinopathy.
    Kjaergaard JJ; Fabrin K; Jensen S; Ditzel J
    Acta Endocrinol Suppl (Copenh); 1980; 238():75-6. PubMed ID: 6933817
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term insulin treatment using continuous subcutaneous insulin infusions: metabolic control and hemorheological aspects].
    Lombardo A; Scornavacca G; Scavino S; Oliva G; Cacciola R; Amantia L; Motta L
    Minerva Endocrinol; 1987; 12(4):289-300. PubMed ID: 3696102
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of the development of retinopathy in treatment with the insulin pump and intensified conventional therapy].
    Bernsmeier H; Cicmir I; Koschinski T; Gries FA
    Fortschr Ophthalmol; 1986; 83(4):467-70. PubMed ID: 3770622
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fluorophotometry and the Fluorotron].
    Menerath JM; Solé P
    Bull Soc Ophtalmol Fr; 1984 Dec; 84(12):1467-71. PubMed ID: 6544674
    [No Abstract]   [Full Text] [Related]  

  • 19. An evaluation of the clinical role of vitreous fluorophotometry.
    McCullough PC; Koester CJ; Campbell CJ; Anderson EA
    Trans Am Ophthalmol Soc; 1983; 81():130-48. PubMed ID: 6676966
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of vascular endothelial growth factor in proliferative diabetic retinopathy.
    Merlak M; Kovacević D; Balog T; Marotti T; Misljenović T; Mikulicić M; Dekaris I
    Coll Antropol; 2008 Oct; 32 Suppl 2():39-43. PubMed ID: 19138004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.